~~<i id='E7EF80DF31'><strike id='E7EF80DF31'><tt id='E7EF80DF31'><pre id='E7EF80DF31'></pre></tt></strike></i>~~

Home» focus» entertainment

entertainment

author：explore 2025-10-02 04:49:34 Page View：312

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sage's campaign to raise awareness of postpartum depression hits a nerve
Next article： Hepatitis C has a cure — but many Americans still lack access to it

comprehensive

Apple is now the first public company to be valued at $3 trillion

6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

JPM 2024: Nvidia claims we're in biological revolution. Are we?

SipaviaAPImagesSANFRANCISCO—Thesmallhotelmeetingroomwaspackedlikearushhoursubway.Bankersindarksuitsw

In age of alternative facts, a scholarly course on calling out crap

Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

Travel bans should be based on evidence, not politics or fear

VALERIEMACON/AFPviaGettyImagesTheTrumpWhiteHouseonMondayreleasedapresidentialproclamationterminating